The analysis of splicing factor survival based on PSI values demonstrates that CDCA5 is significantly related with the overall survival of numerous cancers, including ACC, COAD, BLCA, etc. Knowing these helps answer questions about the pathophysiology of cancer and ultimately confirms CDCA5 as a potential therapy target. Here, CDCA5 is linked to adrenal cortex carcinoma.